Complete IPO calendar HERE
(1) Based in Beltsville, MD, TerraForm Power ($TERP) scheduled a $401 million IPO on the Nasdaq with a market capitalization of $1.87 billion at a price range midpoint of $20 for Friday, July 18, 2014.
TERP is another clean energy ‘carve-out’ from a strong parent. The projected yield of 4.5% at the price range mid-point of $20 is high compared to the sector.
(2) Based in Seattle, WA, Trupanion ($TRUP) scheduled a $100 million IPO on the NYSE with a market capitalization of $372 million at a price range midpoint of $14 for Friday, July 18, 2014.
TRUP appears to be expanding the market for cat and dog insurance, receiving a large percentage of new business from referrals.
(3) Based in Emeryville, CA, TubeMogul ($TUBE) scheduled a $75 million IPO on the NYSE with a market capitalization of $344 million at a price range midpoint of $12 for Friday, July 18, 2014.
TUBE is in the digital branding for enterprises business. TUBE is experiencing explosive growth in platform direct sales.
(4) Based in Luxembourg, Globant S.A. ($GLOB) scheduled a $76 million IPO on the NYSE with a market capitalization of $388.7 million .
Compare towithh EPAM Systems (EPAM) & Cognizant Technology (CTSH) , see report.
(5) Based in Warren, NJ, Roka Bioscience ($ROKA) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $265 million at a price range midpoint of $15 for Thursday, July 17, 2014.
ROKA is a molecular diagnostics company initially focused on providing advanced testing solutions for the detection of foodborne pathogens, which is projected to be the fastest growing segment of the $2 billion food safety testing market.
(6) Based in San Diego, CA, Pfenex ($PFNX) scheduled a $65 million IPO on the NYSE with a market capitalization of $198 million at a price range midpoint of $13 for Friday, July 18, 2014.
PFNX was a December 2009 spinout from The Dow Chemical Company. Pre-IPO shareholders include affiliates of The Dow Chemical Company with 49% and Signet Healthcare Partners with 35%.
PFNX is a clinical-stage biotechnology company engaged in the development of difficult to manufacture and high-value proteins, initially focused on biosimilar therapeutics, or biosimilars.
(7) Based in Cambridge, MA, Sage Therapeutics ($SAGE) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $359 million at a price range midpoint of $15 for Friday, July 18, 2014.
SAGE is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies.
(8) Based in Brisbane, CA, CareDx ($CDNA) scheduled a $50 million IPO on the Nasdaq with a market capitalization of $168 million at a price range midpoint of $16 for Friday, July 18, 2014.
CDNA is a commercial stage company that develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a patient’s lifetime.
(9) Based in Winter Park, FL, iRadimed ($IRMD) scheduled a $9.6 million IPO on the Nasdaq with a market capitalization of $56 million at a price range midpoint of $5.50 for the week of July 14, 2014.
IRMD develops, manufactures, markets and distributes MRI compatible products, and today IRMD is the global market leader in the sale of non-magnetic IV infusion pump systems
Read Next
